BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22161836)

  • 21. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
    Li Y; Wang H; Wang Z; Makhija S; Buchsbaum D; LoBuglio A; Kimberly R; Zhou T
    Cancer Res; 2006 Sep; 66(17):8520-8. PubMed ID: 16951164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p75 neurotrophin receptor is essential for neuronal cell survival and improvement of functional recovery after spinal cord injury.
    Chu GK; Yu W; Fehlings MG
    Neuroscience; 2007 Sep; 148(3):668-82. PubMed ID: 17706365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y; Zhang B
    Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.
    Nalbandian A; Pang AL; Rennert OM; Chan WY; Ravindranath N; Djakiew D
    Differentiation; 2005 Oct; 73(8):385-96. PubMed ID: 16316409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-expression of the P75 neurotrophin receptor and neurotrophin receptor-interacting melanoma antigen homolog in the mature rat brain.
    Barrett GL; Greferath U; Barker PA; Trieu J; Bennie A
    Neuroscience; 2005; 133(2):381-92. PubMed ID: 15878242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells.
    Ruiz-Ruiz C; López-Rivas A
    Biochem J; 2002 Aug; 365(Pt 3):825-32. PubMed ID: 11936954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction.
    Jin H; Wang Z; Liu L; Gao L; Sun L; Li X; Zhao H; Pan Y; Shi H; Liu N; Hong L; Liang J; Wu Q; Yang Z; Wu K; Fan D
    Mol Pharm; 2010 Feb; 7(1):156-68. PubMed ID: 19916560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J; Zhe X
    Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
    Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
    Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
    Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
    Perera CN; Spalding HS; Mohammed SI; Camarillo IG
    Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells.
    Marchetti D; Aucoin R; Blust J; Murry B; Greiter-Wilke A
    J Cell Biochem; 2004 Jan; 91(1):206-15. PubMed ID: 14689592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
    Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
    Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.
    Rachner TD; Benad P; Rauner M; Goettsch C; Singh SK; Schoppet M; Hofbauer LC
    J Cell Biochem; 2009 Sep; 108(1):106-16. PubMed ID: 19544400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.